Listening Session on Data Sharing to Advance Clinical Development of IgAN Therapies
March 7, 2024
Register for the Kidney Health Initiative's (KHI) listening session on data sharing to continue accelerating the clinical development of new therapies for IgAN.
Data sharing helped transform the drug development landscape for IgAN. As we look to the future, clarifying new development pathways to advance potential therapies is critical, and will require examining recent trial and registry data. This listening session aims to understand the perspectives of industry, patients, and their caregivers on the importance of sharing newer data, as well as potential barriers and solutions to sharing newer data.